TORONTO, May 30, 2023 /PRNewswire/ – Cybeats Technologies Corp. (“Cybeats” or the “Company”) (CSE: CYBT) (OTCQB: CYBCF) is pleased to announce a trial license agreement for SBOM Studio1 with a Top-5 global medical device company, marking its 3rd engagement from the Medical Device Manufacturing (“MDM”) Global Top-10. “The interest from yet another global leader from the … Read more
DUBLIN, May 30, 2023 /PRNewswire/ — The “Lab Consumables – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. Global Lab Consumables Market to Reach $17.2 Million by 2030 In the changed post COVID-19 business landscape, the global market for Lab Consumables estimated at US$12.1 Million in the year 2022, is projected to … Read more
NEW YORK, May 30, 2023 /PRNewswire/ — Thorne HealthTech, Inc. (“Thorne”) (the “Company”) (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it will participate in TD Cowen’s 7th Annual Future of the Consumer Conference in New York City. On Wednesday, June 7, at 10:45 a.m. … Read more
ANDOVER, Mass., May 30, 2023 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on May 24, 2023, TransMedics granted non-qualified stock options to purchase an aggregate of 87,472 shares of its common stock and … Read more
DUBLIN, May 30, 2023 /PRNewswire/ — The “Long-term Care Software Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to ResearchAndMarkets.com’s offering. The global long-term care software market is expected to grow at a CAGR of around 10.7% to reach $9.67 billion by 2030 from $4.76 billion in 2023. Companies Mentioned … Read more
EMERYVILLE, Calif., May 30, 2023 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at the following upcoming investor conferences during the month of June: William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6 at 9:20 a.m. CT Goldman Sachs … Read more
PALO ALTO, Calif., May 30, 2023 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, announced today that management will present at the following upcoming investor conferences: Jefferies Healthcare Conference, June 7, 2023, 1:30 PM ET (10:30 AM PT), New … Read more
DUBLIN, May 30, 2023 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 2023 Goldman Sachs Global Healthcare Conference. Company management will participate in a fireside chat on Tuesday, June 13, 2023, at 3:20 p.m. PT / 11:20 p.m. IST. An audio webcast of the fireside chat will … Read more
PHILADELPHIA, May 30, 2023 /PRNewswire/ — Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the Company will present at several healthcare industry conferences in June 2023. These conferences include: 2023 American Society of Clinical Oncology (ASCO) Annual Meeting Yara Abdou, … Read more
TORONTO, May 30, 2023 /PRNewswire/ – SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures respiratory health and precision medicine tests today reported its financial and operational results for the second quarter ended March 31, 2022. Q2 2023 Financial Highlights Sales … Read more